KIN
Nuveen Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-154,713
| Closed | -$769K | – | 3524 |
|
|
2021
Q1 | $769K | Sell |
154,713
-4,021
| -3% | -$20K | ﹤0.01% | 2980 |
|
|
2020
Q4 | $684K | Sell |
158,734
-24,718
| -13% | -$107K | ﹤0.01% | 2935 |
|
|
2020
Q3 | $787K | Buy |
183,452
+41,859
| +30% | +$180K | ﹤0.01% | 2788 |
|
|
2020
Q2 | $636K | Buy |
141,593
+15,158
| +12% | +$68.1K | ﹤0.01% | 2809 |
|
|
2020
Q1 | $505K | Buy |
126,435
+8,807
| +7% | +$35.2K | ﹤0.01% | 2768 |
|
|
2019
Q4 | $997K | Sell |
117,628
-1,485
| -1% | -$12.6K | ﹤0.01% | 2691 |
|
|
2019
Q3 | $816K | Buy |
119,113
+4,663
| +4% | +$31.9K | ﹤0.01% | 2778 |
|
|
2019
Q2 | $954K | Buy |
+114,450
| New | +$954K | ﹤0.01% | 2759 |
|